|
Principal
Applicant
|
Title
of Project
|
Funding
Source and Program
|
Years
of Tenure
|
|
M
Alaoui- Jamali, G. Batist
|
Tissue
Bank infrasturcture
|
FRSQ
Reseau Pharmacologique du cancer
|
1994-1997
|
|
M
Alaoui- Jamali, G Batist, G Burton, A Prhabat
|
Gene
Specific targeting: optimization and potential clinical applications
|
NSERC-strategic
|
1995-1998
|
|
M
Alaoui
|
Regulation
of the DNA repair proteins ERCC2 and ERCC3 by the hepatitis B virus
x protein. Implications for liver carcinogeneisis.
|
Candian
Cancer Research Society
|
1997-1999
|
|
M
Alaoui
|
Regulation
of DNA repair pathways by the ErbB2 tyrosine kinase receptor: Implicationsfor
intrinsic resistance in cancer
|
MRC
|
1997-2000
|
|
M
Alaoui
|
Role
of erbB receptor family of tyrosine kinases in intrinsic drug resistance
of breast cancer.
|
National
Cancer Institute of Canada- Breast Cancer Research Initiative
|
1997-2000
|
|
M
Alaoui- Jamali, D. Laird, G. Batist, C. Naus,
|
Mechanisms
of gap junction down regulation in mammary tumor cells
|
Breast
Cancer Research Initiative of the National Cancer Research Institute
of Canada
|
1997-2000
|
|
M
Alaoui- Jamali, W. Foulkes, G. Batist
|
The
cellular and molecular basis of squamous cell carcinoma of the head
and neck in those with low exposure to tobacco and alcohol.
|
National
Cancer Institute of Canada
|
1999-2002
|
|
M
Alaoui- Jamali
|
Interaction
of the hepatitis B virus with DNA repair mechanisms: Molecular Studies
|
Cancer
Research Society
|
1999-2001
|
|
M
Alaoui- Jamali
|
Biological
Implications of a novel transcriptional activator that is highly
expressed in breast cancer cells
|
Breast
Cancer Research Initiative IDEA Grant (NCIC)
|
2000-2001
|
|
M
Alaoui- Jamali
|
Role
of PKR tumor cell response to stress
|
Cancer
Research Society Inc.
|
2000-2002
|
|
8
Investigators
|
Montreal
Center for Experimental Cancer Pharmacology
|
Canadian
Foundation for Innovation (CFI) and Valorization Recherche en Quebec
|
2001
|
|
M
Alaoui- Jamali
|
ErbB
signaling in breast cancer prognosis: Molecular studies and identification
of therapeutic targets
|
Breast
Cancer Research Initiative of the National Cancer Institute of Canada
|
2001-2003
|
|
M
Alaoui
|
Functional
characterization of novel
protein involved in the regulation of DNA repair mechanisms
|
Canadian
Institute of Health Research (former MRC)
|
2001-2003
|
|
M
Alaoui
|
Developing
inhibitors to DNA metase
|
NCIC
|
1994-1998
|
